相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。A Synthetic DNA, Multi-Neoantigen Vaccine Drives Predominately MHC Class I CD8+ T-cell Responses, Impacting Tumor Challenge
Elizabeth K. Duperret et al.
CANCER IMMUNOLOGY RESEARCH (2019)
Coexpression of Inhibitory Receptors Enriches for Activated and Functional CD8+ T Cells in Murine Syngeneic Tumor Models
Huizhong Xiong et al.
CANCER IMMUNOLOGY RESEARCH (2019)
A non-functional neoepitope specific CD8+ T-cell response induced by tumor derived antigen exposure in vivo
Mathias Vormehr et al.
ONCOIMMUNOLOGY (2019)
Personalized neoantigen vaccines: A new approach to cancer immunotherapy
Amanda R. Aldous et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2018)
Anti-PD-1 and Anti-CTLA-4 Therapies in Cancer: Mechanisms of Action, efficacy, and Limitations
Judith A. Seidel et al.
FRONTIERS IN ONCOLOGY (2018)
Cationic Liposomes: A Flexible Vaccine Delivery System for Physicochemically Diverse Antigenic Peptides
Jeroen Heuts et al.
PHARMACEUTICAL RESEARCH (2018)
MERTK inhibition alters the PD-1 axis and promotes anti-leukemia immunity
Alisa B. Lee-Sherick et al.
JCI INSIGHT (2018)
CD4+ T cell help in cancer immunology and immunotherapy
Jannie Borst et al.
NATURE REVIEWS IMMUNOLOGY (2018)
Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer
Ugur Sahin et al.
NATURE (2017)
An immunogenic personal neoantigen vaccine for patients with melanoma
Patrick A. Ott et al.
NATURE (2017)
PD-L1 expression on malignant cells is no prerequisite for checkpoint therapy
Jan Willem Kleinovink et al.
ONCOIMMUNOLOGY (2017)
A cGAS-Independent STING/IRF7 Pathway Mediates the Immunogenicity of DNA Vaccines
John J. Suschak et al.
JOURNAL OF IMMUNOLOGY (2016)
Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapy
Lena M. Kranz et al.
NATURE (2016)
Immune Checkpoint Targeting in Cancer Therapy: Toward Combination Strategies with Curative Potential
Padmanee Sharma et al.
CELL (2015)
Mutant MHC class II epitopes drive therapeutic immune responses to cancer
Sebastian Kreiter et al.
NATURE (2015)
A dendritic cell vaccine increases the breadth and diversity of melanoma neoantigen-specific T cells
Beatriz M. Carreno et al.
SCIENCE (2015)
Systematic identification of personal tumor-specific neoantigens in chronic lymphocytic leukemia
Mohini Rajasagi et al.
BLOOD (2014)
Predicting immunogenic tumour mutations by combining mass spectrometry and exome sequencing
Mahesh Yadav et al.
NATURE (2014)
Exploiting the Mutanome for Tumor Vaccination
John C. Castle et al.
CANCER RESEARCH (2012)
IL-12 DNA as molecular vaccine adjuvant increases the cytotoxic T cell responses and breadth of humoral immune responses in SIV DNA vaccinated macaques
Rashmi Jalah et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2012)
DNA Vaccines: Developing New Strategies against Cancer
Daniela Fioretti et al.
JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY (2010)
Naive tumor-specific CD4+ T cells differentiated in vivo eradicate established melanoma
Ying Xie et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2010)
Directly Transfected Langerin+ Dermal Dendritic Cells Potentiate CD8+ T Cell Responses following Intradermal Plasmid DNA Immunization
Mazal Elnekave et al.
JOURNAL OF IMMUNOLOGY (2010)
Immune response induced by a linear DNA vector: Influence of dose, formulation and route of injection
Anne Endmann et al.
VACCINE (2010)
Construction of an HBV DNA vaccine by fusion of the GM-CSF gene to the HBV-S gene and examination of its immune effects in normal and HBV-transgenic mice
Yuling Qing et al.
VACCINE (2010)
Equivalent stimulation of naive and memory CD8 T cells by DNA vaccination: a dendritic cell-dependent process
Sammy Bedoui et al.
IMMUNOLOGY AND CELL BIOLOGY (2009)
Induction of T cell-mediated immunity using a c-Myb DNA vaccine in a mouse model of colon cancer
Benjamin B. Williams et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2008)
CD4 cells can be more efficient at tumor rejection than CD8 cells
Ainhoa Perez-Diez et al.
BLOOD (2007)
Immune surveillance of tumors
Jeremy B. Swann et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Enhancement of immune responses to an HBV DNA vaccine by electroporation
A Luxembourg et al.
VACCINE (2006)
A rapid and potent DNA vaccination strategy defined by in vivo monitoring of antigen expression
AD Bins et al.
NATURE MEDICINE (2005)
CD4+T cell-mediated HER-2/neu-specific tumor rejection in the absence of B cells
JA Lindencrona et al.
INTERNATIONAL JOURNAL OF CANCER (2004)
Granulocyte-macrophage colony-stimulating factor priming plus papillomavirus E6 DNA vaccination: Effects on papilloma formation and regression in the cottontail rabbit papillomavirus-rabbit model
SA Leachman et al.
JOURNAL OF VIROLOGY (2000)